874468-54-9

Basic information

• Product Name: [5-(4-AMINO-2-CHLORO-PHENYL)-FURAN-2-YL]-METHANOL
• Synonyms: ASINEX-REAG BAS 13015639;ASISCHEM B52609;ART-CHEM-BB B025452;AKOS BB-7693;[5-(4-AMINO-2-CHLOROPHENYL)-2-FURYL]METHANOL;[5-(4-AMINO-2-CHLORO-PHENYL)-FURAN-2-YL]-METHANOL;TIMTEC-BB SBB009804;BAS 13015639
• CAS NO: 874468-54-9
• Molecular Formula: C11H10ClNO2
• Molecular Weight: 223.66
• Mol File: 874468-54-9.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: [5-(4-AMINO-2-CHLORO-PHENYL)-FURAN-2-YL]-METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: [5-(4-AMINO-2-CHLORO-PHENYL)-FURAN-2-YL]-METHANOL(874468-54-9)
• EPA Substance Registry System: [5-(4-AMINO-2-CHLORO-PHENYL)-FURAN-2-YL]-METHANOL(874468-54-9)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 874468-54-9(Hazardous Substances Data)

Usage

Description

[5-(4-Amino-2-chlorophenyl)furan-2-yl]methanol, also known as AM-2201, is a synthetic cannabinoid that serves as a potent agonist for the cannabinoid receptors CB1 and CB2. It is recognized for its psychoactive effects, which include euphoria, relaxation, and an altered perception of time and space. Despite its recreational use, it poses significant health risks, such as dependency, toxicity, and adverse effects on mental and physical well-being. Consequently, it is classified as a controlled substance in many jurisdictions to mitigate its potential harm.

Uses

Used in Recreational Drug Industry:
[5-(4-Amino-2-chlorophenyl)furan-2-yl]methanol is used as a recreational drug for its psychoactive effects, which include inducing feelings of euphoria, relaxation, and an altered perception of time and space. However, its use is regulated due to the associated risks of dependency, toxicity, and adverse effects on mental and physical health.
Used in Pharmaceutical Research:
In the pharmaceutical industry, [5-(4-Amino-2-chlorophenyl)furan-2-yl]methanol may be utilized in research and development for the study of cannabinoid receptors and the potential therapeutic applications related to these receptors. This could involve the development of new medications or therapies that leverage the agonistic properties of AM-2201 while minimizing the associated risks.